• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract.尿路致病性大肠杆菌在泌尿道中持续存在及清除的机制
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14170-5. doi: 10.1073/pnas.0602136103. Epub 2006 Sep 12.
2
Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.大肠杆菌引起复发性尿路感染的重要细菌特征。
Dan Med Bull. 2011 Apr;58(4):B4187.
3
Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli.肌动蛋白门控的尿路致病性大肠杆菌的细胞内生长与复苏
Cell Microbiol. 2006 Apr;8(4):704-17. doi: 10.1111/j.1462-5822.2006.00691.x.
4
A non-canonical autophagy-dependent role of the ATG16L1 variant in urothelial vesicular trafficking and uropathogenic Escherichia coli persistence.ATG16L1 变异体在非经典自噬依赖性中的作用:对尿路上皮囊泡运输和尿路致病性大肠杆菌持续存在的影响。
Autophagy. 2019 Mar;15(3):527-542. doi: 10.1080/15548627.2018.1535290. Epub 2018 Nov 8.
5
Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.尿路致病性大肠埃希菌在急性和慢性尿路感染期间的种群动态和生态位分布。
Infect Immun. 2011 Oct;79(10):4250-9. doi: 10.1128/IAI.05339-11. Epub 2011 Aug 1.
6
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.面对多种抗生素,尿路致病性大肠杆菌仍持续存在。
Antimicrob Agents Chemother. 2010 May;54(5):1855-63. doi: 10.1128/AAC.00014-10. Epub 2010 Mar 15.
7
Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli.甲氧苄啶-磺胺甲恶唑对感染尿路致病性大肠杆菌的小鼠复发性菌尿和细菌持续性感染的影响。
Infect Immun. 2002 Dec;70(12):7042-9. doi: 10.1128/IAI.70.12.7042-7049.2002.
8
Intracellular Uropathogenic E. coli Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder Cells.细胞内尿路致病性大肠杆菌利用宿主Rab35获取铁并在膀胱细胞内存活。
PLoS Pathog. 2015 Aug 6;11(8):e1005083. doi: 10.1371/journal.ppat.1005083. eCollection 2015 Aug.
9
Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization.尿路致病性大肠杆菌鞭毛有助于在尿路中有效定殖。
Infect Immun. 2005 Nov;73(11):7657-68. doi: 10.1128/IAI.73.11.7657-7668.2005.
10
Ferritinophagy drives uropathogenic Escherichia coli persistence in bladder epithelial cells.铁蛋白自噬促进尿路致病性大肠杆菌在膀胱上皮细胞中的持续存在。
Autophagy. 2016 May 3;12(5):850-63. doi: 10.1080/15548627.2016.1160176.

引用本文的文献

1
Monoclonal antibodies targeting the FimH adhesin protect against uropathogenic UTI.靶向FimH黏附素的单克隆抗体可预防致病性尿路感染。
Sci Adv. 2025 Jun 20;11(25):eadw0698. doi: 10.1126/sciadv.adw0698.
2
A 5-HT-mediated urethral defense against urinary tract infections.5-羟色胺介导的尿道对尿路感染的防御作用。
Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2409754122. doi: 10.1073/pnas.2409754122. Epub 2025 Apr 14.
3
Cranberry constituents prevent SOS-mediated filamentation of uropathogenic .蔓越莓成分可防止尿致病性大肠杆菌由SOS介导的丝状体形成 。
Infect Immun. 2025 May 13;93(5):e0060024. doi: 10.1128/iai.00600-24. Epub 2025 Apr 10.
4
Effects of Selective Serotonin Reuptake Inhibitors and Ondansetron on Urinary Tract Infections in Pregnancy.选择性5-羟色胺再摄取抑制剂和昂丹司琼对妊娠期尿路感染的影响。
Reprod Sci. 2025 Apr;32(4):1155-1165. doi: 10.1007/s43032-025-01826-6. Epub 2025 Mar 5.
5
Infections in the Culture of Catheter Urine Specimens and Bladder Biopsies in Women Undergoing Cystoscopy.接受膀胱镜检查的女性患者导尿管尿液标本及膀胱活检组织培养中的感染情况
Int Urogynecol J. 2025 Feb 24. doi: 10.1007/s00192-025-06086-1.
6
Two-component system GrpP/GrpQ promotes pathogenicity of uropathogenic Escherichia coli CFT073 by upregulating type 1 fimbria.双组分系统GrpP/GrpQ通过上调1型菌毛促进尿路致病性大肠杆菌CFT073的致病性。
Nat Commun. 2025 Jan 11;16(1):607. doi: 10.1038/s41467-025-55982-z.
7
Canine urothelial cell model to study intracellular bacterial community development by uropathogenic Escherichia coli.用于研究致病性大肠杆菌引起的细胞内细菌群落发育的犬膀胱上皮细胞模型。
PLoS One. 2025 Jan 9;20(1):e0316834. doi: 10.1371/journal.pone.0316834. eCollection 2025.
8
Prostatic Escherichia coli infection drives CCR2-dependent recruitment of fibrocytes and collagen production.前列腺大肠杆菌感染驱动CCR2依赖的纤维细胞募集和胶原蛋白生成。
Dis Model Mech. 2025 Jan 1;18(1). doi: 10.1242/dmm.052012. Epub 2025 Jan 24.
9
Monoclonal antibodies targeting the FimH adhesin protect against uropathogenic UTI.靶向FimH黏附素的单克隆抗体可预防致病性尿路感染。
bioRxiv. 2024 Dec 11:2024.12.10.627638. doi: 10.1101/2024.12.10.627638.
10
The rise, fall, and resurgence of phage therapy for urinary tract infection.用于治疗尿路感染的噬菌体疗法的兴衰与复兴
EcoSal Plus. 2024 Dec 12;12(1):eesp00292023. doi: 10.1128/ecosalplus.esp-0029-2023. Epub 2024 Jan 11.

本文引用的文献

1
Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli.肌动蛋白门控的尿路致病性大肠杆菌的细胞内生长与复苏
Cell Microbiol. 2006 Apr;8(4):704-17. doi: 10.1111/j.1462-5822.2006.00691.x.
2
Urinary glycosaminoglycan excretion during the menstrual cycle in normal young women.正常年轻女性月经周期中的尿糖胺聚糖排泄情况。
J Urol. 2005 May;173(5):1789-92. doi: 10.1097/01.ju.0000154621.18695.b7.
3
Intracellular Helicobacter pylori in gastric epithelial progenitors.胃上皮祖细胞内的幽门螺杆菌
Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5186-91. doi: 10.1073/pnas.0407657102. Epub 2005 Mar 28.
4
Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice.大肠杆菌在美西林治疗小鼠膀胱中的细胞内持续性。
J Antimicrob Chemother. 2005 Mar;55(3):383-6. doi: 10.1093/jac/dki002. Epub 2005 Jan 28.
5
Persistent bacterial infections: the interface of the pathogen and the host immune system.持续性细菌感染:病原体与宿主免疫系统的界面
Nat Rev Microbiol. 2004 Sep;2(9):747-65. doi: 10.1038/nrmicro955.
6
Salmonella redirects phagosomal maturation.沙门氏菌会改变吞噬体的成熟过程。
Curr Opin Microbiol. 2004 Feb;7(1):78-84. doi: 10.1016/j.mib.2003.12.005.
7
Bacterial penetration of bladder epithelium through lipid rafts.细菌通过脂筏穿透膀胱上皮。
J Biol Chem. 2004 Apr 30;279(18):18944-51. doi: 10.1074/jbc.M400769200. Epub 2004 Feb 19.
8
Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.尿路致病性大肠杆菌在尿路感染发病机制中的分化与发育途径
Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1333-8. doi: 10.1073/pnas.0308125100. Epub 2004 Jan 22.
9
Defensins: antimicrobial peptides of innate immunity.防御素:天然免疫的抗菌肽。
Nat Rev Immunol. 2003 Sep;3(9):710-20. doi: 10.1038/nri1180.
10
Intracellular bacterial biofilm-like pods in urinary tract infections.尿路感染中的细胞内细菌生物膜样荚膜
Science. 2003 Jul 4;301(5629):105-7. doi: 10.1126/science.1084550.

尿路致病性大肠杆菌在泌尿道中持续存在及清除的机制

Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract.

作者信息

Mysorekar Indira U, Hultgren Scott J

机构信息

Department of Molecular Microbiology, Washington University School of Medicine, Box 8230, 660 South Euclid Avenue, St. Louis, MO 63110, USA.

出版信息

Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14170-5. doi: 10.1073/pnas.0602136103. Epub 2006 Sep 12.

DOI:10.1073/pnas.0602136103
PMID:16968784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1564066/
Abstract

Recurrent urinary tract infections (rUTIs) are a source of considerable morbidity in women. The infecting bacteria in both rUTIs and a de novo acute infection have been thought to originate from an extraurinary location. Here, we show in a murine model of UTI that uropathogenic Escherichia coli (UPEC) established quiescent intracellular reservoirs (QIRs) in Lamp1+ endosomes within the urinary bladder epithelium. Depending on the integrity of the urothelial barriers at the time of initial infection, these QIRs were established within terminally differentiated superficial facet cells and/or underlying transitional epithelial cells. Treatment of infected bladders harboring exclusively superficial facet cell QIRs with the cationic protein, protamine sulfate, led to epithelial exfoliation and eradication of bacteria in 100% of treated animals. However, when the bacterial QIRs were harbored in underlying transitional cells, stimulation of epithelial turnover triggered reemergence of viable organisms and recurrence of infection. Thus, our results suggest (i) that bacterial QIRs within the bladder may be a previously unappreciated source of recurrent UTIs and (ii) that inducing epithelial exfoliation may be a therapeutic avenue for treating this heretofore recalcitrant disease.

摘要

复发性尿路感染(rUTIs)是女性发病的一个重要原因。人们一直认为,rUTIs和初发性急性感染中的感染细菌都源自泌尿外部位。在此,我们在尿路感染的小鼠模型中发现,尿路致病性大肠杆菌(UPEC)在膀胱上皮细胞内的Lamp1 + 内体中建立了静止性细胞内储存库(QIRs)。根据初次感染时尿路上皮屏障的完整性,这些QIRs在终末分化的表层小面细胞和/或下层移行上皮细胞内建立。用阳离子蛋白硫酸鱼精蛋白治疗仅含有表层小面细胞QIRs的感染膀胱,100%的治疗动物出现上皮脱落并清除细菌。然而,当细菌QIRs存在于下层移行细胞中时,刺激上皮更新会引发活菌重新出现和感染复发。因此,我们的结果表明:(i)膀胱内的细菌QIRs可能是复发性UTIs以前未被认识的来源;(ii)诱导上皮脱落可能是治疗这种迄今难以治愈疾病的一种治疗途径。